EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart

Ivan I Galkin iD, Viktoriia V Skopenkova iD, Maria Y Shubina, Anna V Polikarpova iD, Svetlana G Vassilieva iD, Irina M Savchenko, Olga S Lebedeva, Daria V Goliusova iD, Margarita Y Sharikova iD, Vladimir V Gureev iD, Tatiana N Malorodova, Alexey V Deikin und 2 weitere

BioTech · 17.07.2026 · 15 (3) · 55

DOI: 10.3390/biotech15030055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioTech, online erschienen am 17.07.2026. Verfasst von Ivan I Galkin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Modeling and Gene Therapy of Hereditary Diseases, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation, Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adeno-associated virus (AAV) vector-mediated gene transfer is an emerging treatment strategy for severe cardiac disorders with genetic etiology. We refined the AAV toolkit to achieve efficient and selective expression of the therapeutic transgene in mouse hearts.

Methods

Using vectors with a reporter transgene, we evaluated AAV administration routes, AAV serotype tropism to the myocardium, and cardiospecific promoters.

Results

We showed that systemic AAV administration provides potent delivery and uniform transduction of cardiac tissue, outperforming localized injection techniques. The MyoAAV 2A capsid variant enabled an improved heart-to-liver transduction ratio compared to the parental AAV9 serotype. Screening a panel of cardiac and pan-muscular promoters in vitro and in vivo verified the superiority of the cardiac troponin T (cTnT) promoter for robust heart-specific transgene expression. Finally, we demonstrated that the cumulative properties of systemic AAV delivery, the MyoAAV 2A serotype, and the cTnT promoter allowed for efficient cardiac synthesis of the therapeutic transgene—an artificial miRNA designed for the gene suppression strategy of FLNC-related cardiomyopathy.

Conclusions

Our findings establish an effective AAV approach for transgene transfer into the mouse heart and promote the development of gene therapy for cardiac disorders.

Schlagwörter

Stichwörter der Autor:innen

adeno-associated virus vectorscardiac diseasescardiac promotersgene therapymyotropic serotypestransgene delivery

Autor:innen und Institutionen

  • Laboratory of Modeling and Gene Therapy of Hereditary Diseases, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.
  • Laboratory of Genetic Technologies and Genome Editing for Biomedicine and Animal Health, Joint Center for Genetic Technologies, Belgorod National Research University, Belgorod 308015, Russia.
  • Marlin Biotech, Sochi 354340, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.

ORCID-Profile: Ivan I Galkin, Viktoriia V Skopenkova, Anna V Polikarpova, Svetlana G Vassilieva, Daria V Goliusova, Margarita Y Sharikova, Vladimir V Gureev, Tatiana V Egorova, Maryana V Bardina

Förderung

  • The Ministry of Education and Science of the Russian Federation
  • Russian Science Foundation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Galkin, I. I., Skopenkova, V. V., Shubina, M. Y., Polikarpova, A. V., Vassilieva, S. G., Savchenko, I. M., Lebedeva, O. S., Goliusova, D. V., Sharikova, M. Y., Gureev, V. V., Malorodova, T. N., Deikin, A. V., Egorova, T. V., & Bardina, M. V. (2026). AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart. BioTech, 15(3), 55. https://doi.org/10.3390/biotech15030055

Vancouver

Galkin II, Skopenkova VV, Shubina MY, Polikarpova AV, Vassilieva SG, Savchenko IM, et al. AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart. BioTech. 2026;15(3):55. doi:10.3390/biotech15030055

BibTeX
@article{Galkin2026,
  author = {Galkin, Ivan I and Skopenkova, Viktoriia V and Shubina, Maria Y and Polikarpova, Anna V and Vassilieva, Svetlana G and Savchenko, Irina M and Lebedeva, Olga S and Goliusova, Daria V and Sharikova, Margarita Y and Gureev, Vladimir V and Malorodova, Tatiana N and Deikin, Alexey V and Egorova, Tatiana V and Bardina, Maryana V},
  title = {AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart},
  journal = {BioTech},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {55},
  doi = {10.3390/biotech15030055}
}
Kostenlos starten →